Sound wave weapon joins fight against deadly pancreatic cancer
Disease control
Not yet recruiting
This study is testing whether adding a focused ultrasound treatment (called IMD10) to standard chemotherapy helps people with borderline or locally advanced pancreatic cancer live longer. About 136 participants will be randomly assigned to receive either chemotherapy alone or che…
Phase: NA • Sponsor: IMGT Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC